Engineering proteins to tackle life-threatening diseases with an eye on accessibility.
Proteinea makes biotherapeutics design smarter, safer, and faster by leveraging novel deep-learning models & platforms integrated with smart experimental throughput.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2020 | Convertable Note | — | 1 |
500 Global
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
500 Global
|
Yes | Convertable Note |